[Adverse effects of lipid-lowering medications].
Fukumoto
Yoshihiro
Y
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine.
Shimokawa
Hiroaki
H
D000924:Anticholesteremic Agents / Q000009:adverse effects*; D001161:Arteriosclerosis / Q000209:etiology / Q000517:prevention & control; D002995:Clofibric Acid / Q000009:adverse effects; D000075202:Contraindications; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D007475:Ion Exchange Resins / Q000009:adverse effects; D008019:Life Style; D011341:Probucol / Q000009:adverse effects
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D007475:Ion Exchange Resins; D002995:Clofibric Acid; D011341:Probucol